Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Arena enters into marketing and supply agreement with Teva for obesity drug

Arena Pharmaceuticals, Inc. has announced that its subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ with Teva Pharmaceutical Industries Limited's Israeli subsidiary, Abic Marketing Limited.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Zynex appoints new CFO

Zynex, Inc., a medical technology company, has appointed Brian Alleman as its new CFO.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Agilent Technologies introduces new tool for exome sequencing

Agilent Technologies Inc., a provider of bio-analytical and electronic measurement solutions, has introduced the SureSelect Clinical Research Exome.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Consulate Health Care selects Aruba for wireless network upgrade

Aruba Networks, Inc., a provider of network access solutions, has announced that Consulate Health Care, a provider of senior healthcare services, has selected Aruba for a wireless network upgrade.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Pegus Research enters into multi-year enterprise agreement with DATATRAK

DATATRAK International, Inc., a provider of eClinical solutions for clinical trials industry, has announced that Pegus Research has entered a multi-year enterprise agreement for DATATRAK solutions and services.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

AngioDynamics receives contract from Novation for BioFlo products

AngioDynamics Inc., a provider of medical devices for vascular access, has received an innovative technology contract from Novation for its BioFlo PICC and BioFlo Port products.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

HealthCare Partners president and CEO to step down

DaVita HealthCare Partners Inc., a provider of kidney care and health care services, has announced that Craig Samitt, president and CEO of HealthCare Partners, or HCP, is stepping down from HCP effective August 1, 2014.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Baxter reports lower Q2 net income, provides outlook for 2014

Baxter International Inc., a developer of products for hemophilia and immune disorders, has reported that net income for the second quarter ended June 30, 2014 was $520 million, or $0.95 per diluted share, compared to $590 million, or $1.07 per diluted share, for the same quarter ended June 30, 2013. For 2014, the company expects GAAP earnings to be in the range of $4.48 to $4.58 per diluted share.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Jazz Pharmaceuticals and Concert initiate Phase I narcolepsy trial

Jazz Pharmaceuticals plc and Concert Pharmaceuticals, Inc. have initiated a first Phase I clinical trial of JZP-386, a deuterium-containing analog of sodium oxybate - the active ingredient in Xyrem oral solution, indicated for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Getinge Q2 net profit down

Getinge Group, a provider of healthcare products, has reported that net profit attributable to parent company shareholders for the second quarter ended June 30, 2014 was SEK397 million, or SEK1.67 per share, compared to SEK455 million, or SEK1.91 per share, for the second quarter ended June 30, 2013.

Published By MarketLine
23 Jul 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.